D2X is a regulated crypto derivatives exchange in Amsterdam that provides institutional investors with a MiFID II-compliant platform for trading bitcoin and ether futures, operating seven days a week with off-exchange collateral management.

Rege Nephro Co., Ltd. is a clinical-stage biotech company developing treatments for kidney diseases, including Autosomal Dominant Polycystic Kidney Disease and Chronic Kidney Disease, using technology from Kyoto University's Center for iPS Cell Research and Application.

Flashpoint Therapeutics is a company developing nanotechnology-enabled therapeutics for cancer and other diseases, using their proprietary nanotechnology platform to deliver precise combinations of therapeutic components.